Literature DB >> 11486900

Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Dutch neonates.

L J Spaapen1, J A Bakker, C Velter, W Loots, M E Rubio-Gozalbo, P P Forget, L Dorland, T J De Koning, B T Poll-The, H K Ploos van Amstel, J Bekhof, N Blau, M Duran, M E Rubio-Gonzalbo.   

Abstract

Four neonates with a positive phenylalanine screening test (Phe concentrations between 258 and 1250 micromol/L) were investigated further to differentiate between phenylalanine hydroxylase (PAH) deficiency and variant hyperphenylalaninaemia (HPA) forms. In patients 1 and 2 a tetrahydrobiopterin (BH4) load caused a significant decrease of the plasma Phe levels. A combined phenylalanine/BH4 loading test was performed in patients 2, 3 and 4. In the latter two patients, plasma Phe concentrations completely normalized within 8 h after the BH4 load (20 mg/kg). Basal urinary pterins were normal in all four patients. The activity of dihydropteridine reductase (DHPR) was normal in patients 1, 2 and 3 and 50% of control values in patient 4 (not in the range of DHPR-deficient patients). In patient 3 a subsequent phenylalanine loading test with concomitant analysis of plasma biopterins revealed a normal increase of biopterin, excluding a BH4 biosynthesis defect. Pterins and neurotransmitter metabolites in CSF of patients 1, 3 and 4 were normal. DNA mutations detected in the PAH gene of patients 1-4 were A313T, and L367fsinsC; V190A and R243X; A300S and A403V; R241C and A403V. The results are suggestive for mutant PAH enzymes with decreased affinity for the cofactor BH4.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11486900     DOI: 10.1023/a:1010596317296

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

1.  Variant of dihydropteridine reductase deficiency without hyperphenylalaninaemia: effect of oral phenylalanine loading.

Authors:  N Blau; B Thöny; A Renneberg; J M Penzien; K Hyland; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  Mutational spectrum of phenylalanine hydroxylase deficiency in the population resident in Catalonia: genotype-phenotype correlation.

Authors:  J Mallolas; M A Vilaseca; J Campistol; N Lambruschini; F J Cambra; X Estivill; M Milà
Journal:  Hum Genet       Date:  1999-11       Impact factor: 4.132

3.  Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts.

Authors:  L Bonafé; B Thöny; W Leimbacher; L Kierat; N Blau
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

4.  Dihydropteridine reductase activity in eluates from dried blood spots: automation of an assay for a national screening service.

Authors:  I M Surplice; P D Griffiths; A Green; R J Leeming
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

5.  Analysis of reduced forms of biopterin in biological tissues and fluids.

Authors:  T Fukushima; J C Nixon
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

6.  Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.

Authors:  S Kure; D C Hou; T Ohura; H Iwamoto; S Suzuki; N Sugiyama; O Sakamoto; K Fujii; Y Matsubara; K Narisawa
Journal:  J Pediatr       Date:  1999-09       Impact factor: 4.406

7.  Phenylketonuria in The Netherlands: 93% of the mutations are detected by single-strand conformation analysis.

Authors:  C J van der Sijs-Bos; C M Diepstraten; J A Juyn; M Plaisier; J C Giltay; F J van Spronsen; G P Smit; R Berger; J A Smeitink; B T Poll-The; J K Ploos van Amstel
Journal:  Hum Hered       Date:  1996 Jul-Aug       Impact factor: 0.444

8.  Neopterin and biopterin levels in patients with atypical forms of phenylketonuria.

Authors:  J C Nixon; C L Lee; S Milstien; S Kaufman; K Bartholomé
Journal:  J Neurochem       Date:  1980-10       Impact factor: 5.372

9.  Differential diagnosis of hyperphenylalaninaemia by a combined phenylalanine-tetrahydrobiopterin loading test.

Authors:  A Ponzone; O Guardamagna; M Spada; S Ferraris; R Ponzone; L Kierat; N Blau
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

  9 in total
  10 in total

1.  Long-term pharmacological management of phenylketonuria, including patients below the age of 4 years.

Authors:  M L Couce; M D Bóveda; E Valerio; A Pérez-Muñuzuri; J M Fraga
Journal:  JIMD Rep       Date:  2011-09-06

Review 2.  Sapropterin dihydrochloride for phenylketonuria.

Authors:  Usha Rani Somaraju; Marcus Merrin
Journal:  Cochrane Database Syst Rev       Date:  2015-03-27

3.  The spectrum of phenylalanine variations under tetrahydrobiopterin load in subjects affected by phenylalanine hydroxylase deficiency.

Authors:  V Leuzzi; C Carducci; C Carducci; F Chiarotti; C Artiola; T Giovanniello; I Antonozzi
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

Review 4.  Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism.

Authors:  Ania C Muntau; Søren W Gersting
Journal:  J Inherit Metab Dis       Date:  2010-09-08       Impact factor: 4.982

5.  Pharmacokinetics of orally administered tetrahydrobiopterin in patients with phenylalanine hydroxylase deficiency.

Authors:  M R Zurflüh; L Fiori; B Fiege; I Ozen; M Demirkol; K H Gärtner; B Thöny; M Giovannini; N Blau
Journal:  J Inherit Metab Dis       Date:  2006-11-07       Impact factor: 4.982

6.  Tetrahydrobiopterin monotherapy for phenylketonuria patients with common mild mutations.

Authors:  Robert Steinfeld; Alfried Kohlschütter; Johannes Zschocke; Martin Lindner; Kurt Ullrich; Zoltan Lukacs
Journal:  Eur J Pediatr       Date:  2002-07       Impact factor: 3.183

7.  Effect of BH(4) supplementation on phenylalanine tolerance.

Authors:  A Burlina; N Blau
Journal:  J Inherit Metab Dis       Date:  2008-12-09       Impact factor: 4.982

8.  Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience.

Authors:  Iris Scala; Daniela Concolino; Roberto Della Casa; Anna Nastasi; Carla Ungaro; Serena Paladino; Brunella Capaldo; Margherita Ruoppolo; Aurora Daniele; Giuseppe Bonapace; Pietro Strisciuglio; Giancarlo Parenti; Generoso Andria
Journal:  Orphanet J Rare Dis       Date:  2015-02-08       Impact factor: 4.123

9.  Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype.

Authors:  Karen Anjema; Margreet van Rijn; Floris C Hofstede; Annet M Bosch; Carla E M Hollak; Estela Rubio-Gozalbo; Maaike C de Vries; Mirian C H Janssen; Carolien C A Boelen; Johannes G M Burgerhof; Nenad Blau; M Rebecca Heiner-Fokkema; Francjan J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2013-07-10       Impact factor: 4.123

10.  Danger of high-protein dietary supplements to persons with hyperphenylalaninaemia.

Authors:  R Koch; K D Moseley; R Moats; S Yano; R Matalon; F Guttler
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.